DANIEL L FLAGLER
Nursing at 138, Miami, FL

License number
Florida 2662
Issued Date
Aug 28, 2002
Effective Date
Aug 22, 2006
Expiration Date
Dec 31, 2005
Category
Health Care
Type
Certified Nursing Assistant
Address
Address
9011 SW 138Th St, Miami, FL 33176
Phone
(305) 971-2305

Professional information

Daniel Flagler Photo 1

Systems Engineering Manager At Beckman Coulter

Location:
Miami/Fort Lauderdale Area
Industry:
Biotechnology


Daniel Flagler Photo 2

Quantitative Stabilized Cell Reference Control Products And Methods

US Patent:
2007001, Jan 18, 2007
Filed:
Jul 15, 2005
Appl. No.:
11/183132
Inventors:
John Maples - Miami FL, US
Rhonda Mills - Pembroke Pines FL, US
Daniel Flagler - Miami FL, US
Cecilia Smith - Lake Placid FL, US
Assignee:
Beckman Coulter, Inc. - Fullerton CA
International Classification:
C12Q 1/00, G01N 33/567, G01N 33/53
US Classification:
435004000, 435007200, 977900000
Abstract:
The invention relates to quantitative stabilized cell reference control products, their methods of manufacture, and their methods of use. Receptors, antigens, and ligands associated with stabilized cells may be quantitated by the methods of the present invention. Those quantitated stabilized cells may then be used to determine the receptor, antigen, and/or ligand density of unknown samples.


Daniel Flagler Photo 3

Formaldehyde-Ammonium Salt Complexes For The Stabilization Of Blood Cells

US Patent:
6913932, Jul 5, 2005
Filed:
Aug 23, 2002
Appl. No.:
10/226825
Inventors:
John A. Maples - Miami FL, US
Lori A. Charie - Pembroke Pines FL, US
Daniel James Flagler - Miami FL, US
Rhonda Ann Mills - Pembroke Pines FL, US
Richard Timmons - Miami FL, US
Assignee:
Beckman Coulter, Inc. - Fullerton CA
International Classification:
G01N033/00, G01N001/00
US Classification:
436176, 436 8, 436 18, 436111, 436128, 436130, 436 63, 436 69, 422 61, 2524081
Abstract:
A stabilization reagent composition, particularly desirable for stabilizing blood samples containing platelets, contains reactants that generate multiple species of formaldehyde-ammonium complexes; at least one inhibitor of phosphatase enzymatic activity; and at least one inhibitor of protease enzymatic activity. Blood samples and other tissues are stabilized by this composition. Such stabilized samples are produced by methods for stabilizing the tissue by contacting the sample with the composition.